Replace Animal Experiments Research Articles

Brazil Moves Toward the Replacement of Animal Experimentation.

In Brazil, efforts towards the regulatory acceptance and implementation of innovative methods to replace experimental animal use in various fields began to gather force in 2008, with the approval of Law No. 11,794/2008 (the Arouca Law). This law represented a milestone, as it created the National Council for the Control of Animal Experimentation (CONCEA) to deal with the ethical and legal issues related to the use of laboratory animals. In 2014, CONCEA put together a framework for expanding the implementation of non-animal methodologies for use in research and education. It also promoted the regulatory acceptance in Brazil of 24 test guidelines, including 15 in vitro approaches. It should be emphasised that, in Brazilian legislation, replacement is generally based on the toxicological endpoint and not on the category of product, as tends to be the case in other countries (e.g. cosmetics in the European Union). The resolution-dependent deadlines for the obligatory replacement of in vivo methods with the CONCEA-approved tests are 2019 and 2021. Brazil has advanced considerably towards the replacement of animal experimentation, and in certain aspects, this has been in a highly progressive manner. However, there is still a lot of work to be done, especially considering the current political scenario with reduced investment in research, development and innovation. The chronology of significant events following the approval of the Arouca Law, which have contributed to the promotion of the Three Rs alternatives in Brazil, will be examined.

Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma.

Survival rates of osteosarcoma patients could not be significantly improved by conventional chemotherapeutic treatment regimens since the introduction of high-dose chemotherapy 35 years ago. Therefore, there is a strong clinical need for new therapeutic targets and personalized treatment strategies, requiring reliable in vivo model systems for the identification and testing of potential new treatment approaches. Conventional in vivo rodent experiments face ethical issues, are time consuming and costly, being of particular relevance in orphan diseases like osteosarcoma. An attractive alternative to such animal experiments is the chicken chorioallantoic membrane (CAM) assay. The CAM is a highly vascularized, non-innervated extra-embryonic membrane that is perfectly suited for the engraftment of tumor cells. However, only few reports are available for osteosarcoma and reported data are inconsistent. Therefore, the aim of this study was the adaptation and optimization of the CAM assay for its application in osteosarcoma research. Tumor take rates and volumes of osteosarcoma that developed on the CAM were analyzed after modification of several experimental parameters, including egg windowing, CAM pretreatment, inoculation technique and many more. Eight osteosarcoma cell lines were investigated. Our optimized OS-CAM-assay was finally validated against a rat animal xenograft model. Using the cell line MNNG HOS as reference we could improve the tumor take rates from 51% to 94%, the viability of the embryos from initially 40% to >80% and achieved a threefold increase of the tumor volumes. We were able to generate solid tumors from all eight osteosarcoma cell lines used in this study and could reproduce results that were obtained using an osteosarcoma rat animal model. The CAM assay can bridge the gap between in vitro cell culture and in vivo animal experiments. As reliable in vivo model for osteosarcoma research the optimized CAM assay may speed up preclinical data collection and simplifies research on potential new agents towards personalized treatment strategies. Further, in accordance with Russell’s and Burch’s “Principles of Humane Experimental Technique” the reasonable use of this model provides a refinement by minimizing pain and suffering of animals and supports a considerable reduction and/or replacement of animal experiments.

Towards animal-free neurotoxicity screening: Applicability of hiPSC-derived neuronal models for in vitro seizure liability assessment_suppl

A sizeable proportion of drug attrition is due to drug-induced seizures. Currently available animal models frequently fail to predict human seizure liability. Therefore, there is a need for in vitro alternatives, preferably based on human-derived neurons, to circumvent interspecies translation. The increasing number of commercially available human induced plurip­otent stem cell (hiPSC)-derived neuronal models holds great promise for replacing rodent primary cultures. We therefore tested three different hiPSC-derived neuronal models for their applicability for in vitro seizure liability assessment. Using immunofluorescent staining and multi-well micro-electrode arrays, we show that all models develop functional neuronal networks that exhibit spontaneous activity and (network) bursting behavior. Development of activity patterns differed between the models, probably due to differences in model composition and seeding density. Neuronal activity and (network) bursting was reproducibly modulated with the seizurogenic compounds strychnine, picrotoxin (PTX) and 4-aminopyridine (4-AP). However, the sensitivity and degree of chemical-induced effects differed between the models, which can likely be explained by differences in seeding density, maturation and different ratios of inhibitory and excit­atory cell types. Importantly, compared to rat primary cortical neurons, the hiPSC-derived neuronal models were equally, or even better in the case of 4-AP, suited to detect seizurogenicity. Overall, our data indicate that hiPSC-derived neuronal models may be used as a first screening tool for in vitro seizure liability assessment. However, before hiPSC-derived neu­ronal models can fully replace animal experiments, more compounds should be tested and the available models must be further characterized to fully understand their applicability.

Towards animal-free neurotoxicity screening: Applicability of hiPSC-derived neuronal models for in vitro seizure liability assessment.

A sizeable proportion of drug attrition is due to drug-induced seizures. Current available animal models frequently fail to predict human seizure liability. Therefore, there is a need for in vitro alternatives, preferably based on human-derived neurons to circumvent interspecies translation. The increasing number of commercially available human induced pluripotent stem cell (hiPSC)-derived neuronal models holds great promise for replacing rodent primary cultures. We therefore tested three different hiPSC-derived neuronal models for their applicability for in vitro seizure liability assessment. Using immunofluorescent staining and multi-well micro-electrode arrays we show that all models develop functional neuronal networks that exhibit spontaneous activity and (network) bursting behavior. Developmental patterns differ between the models, probably due to differences in model composition and seeding density. Nevertheless, neuronal activity and (network) bursting can be reproducibly modulated with the seizurogenic compounds strychnine, picrotoxin (PTX) and 4-aminopyridine (4-AP). However, the sensitivity and degree of chemical-induced effects differs between the models, which can likely be explained by differences in seeding density, maturation and different ratios of inhibitory and excitatory cell types. Importantly, compared to rat primary cortical neurons, the hiPSC-derived neuronal models were equally, or even better in the case of 4-AP, suited to detect seizurogenicity. Overall, our data indicate that hiPSC-derived neuronal models may in the future be used as a first screening tool for in vitro seizure liability assessment. However, before hiPSC-derived neuronal models can fully replace animal experiments, more compounds should be tested and the available models must be further characterized to fully understand their applicability.

From bed to bench: How in silico medicine can help ageing research

Driven by the raising ethical concerns surrounding animal experimentation, there is a growing interest for non-animal methods, in vitro or in silico technologies that can be used to reduce, refine, and replace animal experimentation. In addition, animal experimentation is being critically revised in regard to its ability to predict clinical outcomes. In this manuscript we describe an initial exploration where a set of in vivo imaging based subject-specific technologies originally developed to predict the risk of femoral strength and hip fracture in osteoporotic patients, were adapted to assess the efficacy of bone drugs pre-clinically on mice. The CT2S technology we developed generates subject-specific models based on Computed Tomography that can separate fractured and non-fractured patients with an accuracy of 82%. When used in mouse experiments the use of in vivo imaging and modelling was found to improve the reproducibility of Bone Mineral Content measurements to a point where up to 63% less mice would be required to achieve the same statistical power of a conventional cross-sectional study. We also speculate about a possible approach where animal-specific and patient-specific models could be used to better translate the observation made on animal models into predictions of response in humans.

Predicting the in vivo pulmonary toxicity induced by acute exposure to poorly soluble nanomaterials by using advanced in vitro methods

BackgroundAnimal models remain at that time a reference tool to predict potential pulmonary adverse effects of nanomaterials in humans. However, in a context of reduction of the number of animals used in experimentation, there is a need for reliable alternatives. In vitro models using lung cells represent relevant alternatives to assess potential nanomaterial acute toxicity by inhalation, particularly since advanced in vitro methods and models have been developed. Nevertheless, the ability of in vitro experiments to replace animal experimentation for predicting potential acute pulmonary toxicity in human still needs to be carefully assessed.The aim of the study was to evaluate the differences existing between the in vivo and the in vitro approaches for the prediction of nanomaterial toxicity and to find advanced methods to enhance in vitro predictivity. For this purpose, rats or pneumocytes in co-culture with macrophages were exposed to the same poorly soluble and poorly toxic TiO2 and CeO2 nanomaterials, by the respiratory route in vivo or using more or less advanced methodologies in vitro. After 24 h of exposure, biological responses were assessed focusing on pro-inflammatory effects and quantitative comparisons were performed between the in vivo and in vitro methods, using compatible dose metrics.ResultsFor each dose metric used (mass/alveolar surface or mass/macrophage), we observed that the most realistic in vitro exposure method, the air-liquid interface method, was the most predictive of in vivo effects regarding biological activation levels. We also noted less differences between in vivo and in vitro results when doses were normalized by the number of macrophages rather than by the alveolar surface. Lastly, although we observed similarities in the nanomaterial ranking using in vivo and in vitro approaches, the quality of the data-set was insufficient to provide clear ranking comparisons.ConclusionsWe showed that advanced methods could be used to enhance in vitro experiments ability to predict potential acute pulmonary toxicity in vivo. Moreover, we showed that the timing of the dose delivery could be controlled to enhance the predictivity. Further studies should be necessary to assess if air-liquid interface provide more reliable ranking of nanomaterials than submerged methods.

2016 Lush Lobbying Prize Winner: 1R Institute of Promotion and Research for the Replacement of Animal Experimentation, Brazil

2016 Lush Lobbying Prize Winner: 1R Institute of Promotion and Research for the Replacement of Animal Experimentation, Brazil

High-throughput prediction of nephrotoxicity in humans.

The Lush Science Prize 2016 was awarded to Daniele Zink and Lit-Hsin Loo for the interdisciplinary and collaborative work between their research groups in developing alternative methods for the prediction of nephrotoxicity in humans. The collaboration has led to the establishment of a series of pioneering alternative methods for nephrotoxicity prediction, which includes: predictive gene expression markers based on pro-inflammatory responses; predictive in vitro cellular models based on pluripotent stem cell-derived proximal tubular-like cells; and predictive cellular phenotypic markers based on chromatin and cytoskeletal changes. A high-throughput method was established for chemical testing, which is currently being used to predict the potential human nephrotoxicity of ToxCast compounds in collaboration with the US Environmental Protection Agency. Similar high-throughput imaging-based methodologies are currently being developed and adapted by the Zink and Loo groups, to include other human organs and cell types. The ultimate goal is to develop a portfolio of methods accepted for the accurate prediction of human organ-specific toxicity and the consequent replacement of animal experiments.

Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery.

The tumour microenvironment is critical to both the initiation and maintenance of tumorigenesis. Reconstitution of the microenvironment is a major challenge for invitro cancer models. Indeed, conventional 2D culture systems cannot replicate the complexity, diversity and dynamic nature of the tumour microenvironment. In this study, we have developed a 3D endotheliazed vesical equivalent by using tissue engineering from primary human cells in which non-invasive or invasive bladder cancer (BCa) cell lines, cultured as compact spheroids, were incorporated. Invasive BCa cells cross the basement membrane and invade the stromal compartment whereas non-invasive BCa cells are confined to the urothelium. Our 3D BCa model could be used as a reliable model for assessing drug responses, potentially reducing or partially replacing animal experiments, and thus should have applications in the identification of novel targets as well as toxicological evaluation of anti-cancer therapies.

Archiving of zebrafish lines can reduce animal experiments in biomedical research.

The use of animals in scientific research in Europe is governed by the DIRECTIVE 2010/63/EU of 22 September 2010. This framework is built on the 3R principle with the aim to reduce, refine and replace animal experiments to the indispensable minimum and to conduct them humanely [1]. Careful experimental planning and statistical evaluation can reduce the number of animals necessary for an experiment. Refinement can, for example, include appropriate analgesia and anaesthesia, the improvement of assay procedures and non‐invasive methods. The third and most rigorous strategic line of the 3R principle is the replacement of animals altogether by in vitro methods including cell, organ and embryo culture or by in silico simulation. Since its adoption in 2010, DIRECTIVE 2010/63/EU has been implemented by national legal guidelines such as the Animal Protection Act (TierSchG—Tierschutzgesetz) in Germany. The administrative burden for scientists has increased along with the new guidelines, prompting researchers to avoid this additional workload by employing of alternative research models. Big hopes rest on artificial stem cell‐derived in vitro organ systems. However, significant technological advances are still required to faithfully reproduce organ function in vitro . In addition, many studies involving interactions at a system level or complex behavioural outcomes require the intact animal model. The zebrafish embryo is increasingly used as an alternative model system. Many aspects of biology, including disease …

Validation and regulatory acceptance of bio-based approaches to assure feedstock, water & product quality in a bio-based economy

Chemical analytical techniques and animal experiments are widely used and well-grounded in regulatory frameworks for safety evaluation of chemicals, products, waste streams and the environment. Although successful in the past to identify and solve problems related to highly persistent and toxic chemicals, these methods are not sufficient for current safety issues that need rapid evaluation of large numbers of chemicals, and assessment of their combined toxicity in mixtures. This is particularly relevant in a bio-based economy in which evaluation of complex mixtures of relatively non-toxic chemicals in e.g. feedstocks, residues and bio-based products is the most relevant safety issue to consider. Bio-based approaches, and particularly modern effect based bioassays show great promise to be used to compliment and partly replace animal experiments and chemical analytical methods in safety assessment. Their speed, high capacity and the possibility to assess effects of mixtures provide unique properties not equaled by conventional methods. By using these advantages safety testing can be modernized and obvious gaps can be filled. To further integrate bio-analysis in safety testing, regulatory acceptance is an important step, which requires validation and the establishment of realistic trigger values. Unfortunately, the process of integration of these novel tools in current regulations and guidelines is slow. In the past decade, however, important progress has been made which paves the way for better acceptance and application of these novel analytical tools. Here, validation strategies for formal validation of effect-based bio-analytical methods are described, exemplified by our experience with effect-based CALUX bioassays. In addition, as a final, but essential step towards full application establishment of effect-based trigger values and inclusion in regulatory frameworks for risk assessment is described. These approaches can be used as a guidance for promoting regulatory acceptance and application of additional effect-based bio-based assays to assure safety in a bio-based economy.

The novel induction of retinal ganglion cell apoptosis in porcine organ culture by NMDA - an opportunity for the replacement of animals in experiments.

Some of the advantages of retina organ culture models include their efficient and easy handling and the ability to standardise relevant parameters. Additionally, when porcine eyes are obtained from the food industry, no animals are killed solely for research purposes. To induce retinal degeneration, a commonly used toxic substance, N-methyl-D-aspartate (NMDA), was applied to the cultures. To this end, organotypic cultures of porcine retinas were cultured and treated with different doses of NMDA (0 [control], 50, 100 and 200μM) on day 2 for 48 hours. On day 7, the retinas were cryo-conserved for histological, Western blot and quantitative rt-PCR (qrt-PCR) analyses. NMDA treatment was found to significantly increase retinal ganglion cell (RGC) apoptosis in all the treated groups, without a profound RGC loss. In addition, the intrinsic apoptotic pathway was activated in the 50μM and 100μM NMDA groups, whereas induced nitric oxide synthase (iNOS) expression was increased in the 200μM group. A slight microglial response was detectable, especially in the 100μM group. NMDA treatment induced apoptosis, oxidative stress and a slight microglia activation. All these effects mimic a chronic slow progressive disease that especially affects RGCs, such as glaucoma. A particular advantage of this model is that mediators that can interact in the very early stages of the onset of RGC death, can be easily detected and potential therapies can be tested.

In silico modeling for tumor growth visualization.

BackgroundCancer is a complex disease. Fundamental cellular based studies as well as modeling provides insight into cancer biology and strategies to treatment of the disease. In silico models complement in vivo models. Research on tumor growth involves a plethora of models each emphasizing isolated aspects of benign and malignant neoplasms. Biologists and clinical scientists are often overwhelmed by the mathematical background knowledge necessary to grasp and to apply a model to their own research.ResultsWe aim to provide a comprehensive and expandable simulation tool to visualizing tumor growth. This novel Web-based application offers the advantage of a user-friendly graphical interface with several manipulable input variables to correlate different aspects of tumor growth. By refining model parameters we highlight the significance of heterogeneous intercellular interactions on tumor progression. Within this paper we present the implementation of the Cellular Potts Model graphically presented through Cytoscape.js within a Web application. The tool is available under the MIT license at https://github.com/davcem/cpm-cytoscapeand http://styx.cgv.tugraz.at:8080/cpm-cytoscape/.ConclusionIn-silico methods overcome the lack of wet experimental possibilities and as dry method succeed in terms of reduction, refinement and replacement of animal experimentation, also known as the 3R principles. Our visualization approach to simulation allows for more flexible usage and easy extension to facilitate understanding and gain novel insight. We believe that biomedical research in general and research on tumor growth in particular will benefit from the systems biology perspective.

A Web-based Alternative Non-animal Method Database for Safety Cosmetic Evaluations.

Animal testing was used traditionally in the cosmetics industry to confirm product safety, but has begun to be banned; alternative methods to replace animal experiments are either in development, or are being validated, worldwide. Research data related to test substances are critical for developing novel alternative tests. Moreover, safety information on cosmetic materials has neither been collected in a database nor shared among researchers. Therefore, it is imperative to build and share a database of safety information on toxicological mechanisms and pathways collected through in vivo, in vitro, and in silico methods. We developed the CAMSEC database (named after the research team; the Consortium of Alternative Methods for Safety Evaluation of Cosmetics) to fulfill this purpose. On the same website, our aim is to provide updates on current alternative research methods in Korea. The database will not be used directly to conduct safety evaluations, but researchers or regulatory individuals can use it to facilitate their work in formulating safety evaluations for cosmetic materials. We hope this database will help establish new alternative research methods to conduct efficient safety evaluations of cosmetic materials.

CONTEMPORARY LEGAL REQUIREMENTS AND ETHICAL PRINCIPLES IN ANIMAL EXPERIMENTATION

Background The experiments on animals remain to play an important and yet unreplaceble role in the progress of biomedicine. Therefore, under certain legal conditions, it is morally acceptable to use animals for scientific purposes. Directive 86/609/EEC adopted in 1986 has started to regulate the legislation on the protection of animals used for scientific purposes in Europe and in Slovenia. In 2010, after a public consultation involving scientific community and animal protectionist associations, the European parliament released revised Directive 2010/63/EU on the protection of animals used for scientific purposes. The aim of the paper is to present contemporary legislation from the field of experimental animals and basic ethical principles that are foundation of responsible use of animals in research as well as valid science. Conclusion The society`s relationship to the animals varies throughtout history, also thanks to animal experimentation which definitively confirmed that animals are sentient beings that like humans experience pain, suffering, distres or enjoyment. In western developed society the number of people defending animal rights and contradicting the use of animals in experiments is increasing. Therefore, increasing effort and financial stimulation for the development and implementation of the methods to replace animal experimentation takes place in the EU. But as long as this does not occur the revised legislation requires careful and responsible use of animals in accordance with the legislative and contemporary ethical principles.

SODOBNA PRAVNA UREDITEV IN ETIČNA NAČELA POSKUSOV NA ŽIVALIH

BackgroundThe experiments on animals remain to play an important and yet unreplaceble role in the progress of biomedicine. Therefore, under certain legal conditions, it is morally acceptable to use animals for scientific purposes. Directive 86/609/EEC adopted in 1986 has started to regulate the legislation on the protection of animals used for scientific purposes in Europe and in Slovenia. In 2010, after a public consultation involving scientific community and animal protectionist associations, the European parliament released revised Directive 2010/63/EU on the protection of animals used for scientific purposes. The aim of the paper is to present contemporary legislation from the field of experimental animals and basic ethical principles that are foundation of responsible use of animals in research as well as valid science. ConclusionThe society`s relationship to the animals varies throughtout history, also thanks to animal experimentation which definitively confirmed that animals are sentient beings that like humans experience pain, suffering, distres or enjoyment. In western developed society the number of people defending animal rights and contradicting the use of animals in experiments is increasing. Therefore, increasing effort and financial stimulation for the development and implementation of the methods to replace animal experimentation takes place in the EU. But as long as this does not occur the revised legislation requires careful and responsible use of animals in accordance with the legislative and contemporary ethical principles.

Cell Cycle Regulation and Apoptotic Responses of the Embryonic Chick Retina by Ionizing Radiation.

Ionizing radiation (IR) exerts deleterious effects on the developing brain, since proliferative neuronal progenitor cells are highly sensitive to IR-induced DNA damage. Assuming a radiation response that is comparable to mammals, the chick embryo would represent a lower vertebrate model system that allows analysis of the mechanisms underlying this sensitivity, thereby contributing to the reduction, refinement and replacement of animal experiments. Thus, this study aimed to elucidate the radiation response of the embryonic chick retina in three selected embryonic stages. Our studies reveal a lack in the radiation-induced activation of a G1/S checkpoint, but rapid abrogation of G2/M progression after IR in retinal progenitors throughout development. Unlike cell cycle control, radiation-induced apoptosis (RIA) showed strong variations between its extent, dose dependency and temporal occurrence. Whereas the general sensitivity towards RIA declined with ongoing differentiation, its dose dependency constantly increased with age. For all embryonic stages RIA occurred during comparable periods after irradiation, but in older animals its maximum shifted towards earlier post-irradiation time points. In summary, our results are in good agreement with data from the developing rodent retina, strengthening the suitability of the chick embryo for the analysis of the radiation response in the developing central nervous system.

Neuronal in vitro activity is more sensitive to valproate than intracellular ATP: Considerations on conversion problems of IC50 in vitro data for animal replacement

We investigated the effects of acute valproate (VPA) on mouse embryonic primary cortex cells (MEPCs). Intracellular ATP concentrations were compared with changes in the mean action potential (AP) frequencies of MEPC networks growing on microelectrode arrays. Our data implies biphasic reactions towards increasing VPA concentrations for both parameters. Intracellular ATP and mean AP frequencies increased around characteristic concentrations of 0.15 and 0.07mM to hormetic plateaus of approx. 120% and 160% of their controls, before fading around 17 and 1.7 mM, respectively. The biphasic in vitro behavior of the two parameters hinders a simple extraction of IC50 and Hillslope values. Different ways of data-fitting with single and double logistic functions are discussed. For a typical hormetic increase of 60% above control, IC50 and Hillslope were decreased by 37% and 15%, respectively. Despite these marginal effects at a logarithmic concentration scale, the hormetic and double logistic behavior of parameters may provide information on the mode of action of toxic compounds. Comparison of our values with the LD50 of mice, recalculated by normalization to body mass, suggests that a neurotoxic rather than a cytotoxic mechanism is killing the animals. The future use of cellular microsystems to replace animal experiments will motivate the development of new microsensors, as well as the consideration of newly accessible parameters in systems biology models.

In vitro 3-D multicellular models for cytotoxicity assay and drug screening

Three-dimensional (3-D) cell culture models have been developed to improve drug screening and predictive efficacy. In this study, a high-throughput drug screening system with autofluorescent cells cultured in 3-D polyethylene terephthalate (PET) scaffolds mimicking in vivo microenvironment was developed. Using a modified microbioreactor platform designed specifically for 3-D cell cultures, three commonly used drugs, 5-fluorouracil (5-FU), gemcitabine, and sodium butyrate, were tested for their cytotoxicity on 3-D mouse embryonic stem (mES) cells and human colon cancer HT-29 cells, respectively. In general, 3-D cultures with multicellular structures exhibited similar expression in Ki-67 (a proliferation marker) and p27kip1 (a quiescence marker) as compared to fresh tissues, and gave better predictive values of effective drug dosage in vivo. The 3-D multicellular mES and HT-29 cultures could be used as more reliable models for assessing dose-dependent drug responses, potentially reducing or partially replacing animal experiments, and thus should have applications in the early-stage drug discovery as well as toxicological evaluation of chemical compounds.

Toward the Replacement of Animal Experiments through the Bioinformatics-driven Analysis of 'Omics' Data from Human Cell Cultures.

This paper outlines the work for which Roland Grafström and Pekka Kohonen were awarded the 2014 Lush Science Prize. The research activities of the Grafström laboratory have, for many years, covered cancer biology studies, as well as the development and application of toxicity-predictive in vitro models to determine chemical safety. Through the integration of in silico analyses of diverse types of genomics data (transcriptomic and proteomic), their efforts have proved to fit well into the recently-developed Adverse Outcome Pathway paradigm. Genomics analysis within state-of-the-art cancer biology research and Toxicology in the 21st Century concepts share many technological tools. A key category within the Three Rs paradigm is the Replacement of animals in toxicity testing with alternative methods, such as bioinformatics-driven analyses of data obtained from human cell cultures exposed to diverse toxicants. This work was recently expanded within the pan-European SEURAT-1 project (Safety Evaluation Ultimately Replacing Animal Testing), to replace repeat-dose toxicity testing with data-rich analyses of sophisticated cell culture models. The aims and objectives of the SEURAT project have been to guide the application, analysis, interpretation and storage of 'omics' technology-derived data within the service-oriented sub-project, ToxBank. Particularly addressing the Lush Science Prize focus on the relevance of toxicity pathways, a 'data warehouse' that is under continuous expansion, coupled with the development of novel data storage and management methods for toxicology, serve to address data integration across multiple 'omics' technologies. The prize winners' guiding principles and concepts for modern knowledge management of toxicological data are summarised. The translation of basic discovery results ranged from chemical-testing and material-testing data, to information relevant to human health and environmental safety.